These PIK3CA-mutations render EGFR-mutant NSCLC cell lines resistant to EGFR-TKIs by activating AKT-signaling and inhibiting TKI-induced apoptosis [38]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.